InspireMD (NSPR) 8-K28 May 24InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at Study results to support a Premarket Approval (PMA) application to FDA in H2 2024Financial data

Company Profile

There was a problem viewing the Excel data due to the size of the original file or a possible file corruption.

We’ve been notified of the problem and will try to fix it as soon as possible.

Back to: